title: Reversible Huntington's disease?
authors.forename: R M
authors.initials: RM
authors.lastname: Bonelli
authors.forename: P
authors.initials: P
authors.lastname: Költringer
authors.forename: L
authors.initials: L
authors.lastname: Kenner
authors.forename: F
authors.initials: F
authors.lastname: Reisecker
authors.forename: R
authors.initials: R
authors.lastname: Bonelli
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D002421:Caudate Nucleus / Q000473:pathology; D018450:Disease Progression; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008803:Mianserin / Q000627:therapeutic use; D008875:Middle Aged; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents; D008803:Mianserin; D006220:Haloperidol